Low Cost Standard Therapeutics Opposition, Glecaprevir / Pibrentasvir, (201817002543)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Natco Pharma Ltd. opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)
Countries: India Date: 2014
-
Indian Pharmaceutical Alliance (IPA) opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)
Countries: India Date: 2014
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)
Countries: India Date: 2014
-
Natco Pharma Ltd. opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)
Countries: India Date: 2014
-
Sankalp Rehabilitation Trust opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)
Countries: India Date: 2015
-
Sankalp Rehabilitation Trust, Hepatitis C Coalition of Nagaland (HepCon) and Asia Network of Positive People (APN+) opposition, Sofosbuvir , (3658/KOLNP/2009)
Countries: India Date: 2014
-
India Cares Foundation opposition, Sofosbuvir, (6087/DELNP/2005)
Countries: India Date: 2015
-
Optimus Pharma Ltd. opposition, Sofosbuvir, (6087/DELNP/2005)
Countries: India Date: 2015
-
BDR Pharmaceuticals Ltd. opposition, SOFOSBUVIR, (6087/DELNP/2005)
Countries: India Date: 2015
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (PCT/US2012/065681 (4351/DELNP/2013))
Countries: India Date: 2017